Following from our previous post, on 3 June 2011, the Federal Government released its responses to the Advisory Council on Intellectual Property (ACIP) report entitled Post-Grant Patent Enforcement Strategies. 

Last week the Patent Office granted what must be a record extension of time under the extension of time provisions of the Patents Act (section 223). 

Australian biotech company Genetic Technologies (GTG) has announced that it has launched a third round of litigation against US biotech and life sciences companies it says are infringing its patented non-coding DNA technology.

Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year.

Just over 3 months after the Therapeutic Goods Legislation Amendment (Copyright) Bill 2011 was introduced into Parliament, and 2 weeks after it was passed unamended, the Governor General has given her Royal Assent to the Bill.